Alexandra Kutzelnigg
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson's Disease: A Randomized, Placebo-Controlled, Phase 1 Study.
Journal: Journal of Parkinson's disease
Published: June 07, 2021
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9.
Journal: European journal of clinical pharmacology
Published: March 09, 2021
A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 27, 2020
Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial.
Journal: The Lancet. Neurology
Published: December 13, 2019
Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.
Journal: Human brain mapping
Published: March 30, 2016
The effects of atomoxetine on emotional control in adults with ADHD: An integrated analysis of multicenter studies.
Journal: European psychiatry : the journal of the Association of European Psychiatrists
Published: September 09, 2014
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: June 06, 2014
Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study.
Journal: International journal of bipolar disorders
Published: February 17, 2014
Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
Journal: Handbook of clinical neurology
Published: February 11, 2014
Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines.
Journal: Current medical research and opinion
Published: June 08, 2013
Baseline characteristics of European and non-European adult patients with attention deficit hyperactivity disorder participating in a placebo-controlled, randomized treatment study with atomoxetine.
Journal: Child and adolescent psychiatry and mental health
Published: July 18, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026